Search

Search Results

• Immune Biomarker Signature in the Diagnostic Workup of Fever Without Source: A Pilot Study

  Angela Maria Di Francesco, Giuliana Pasciuto, Laura Gerardino, Ludovico Luca Sicignano, Elena Verrecchia, Andrea Urbani, Donato Rigante, Raffaele Manna

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.030

  496

  PDF: 394

  HTML: 154

• A retrospective descriptive study characterizing coronavirus disease epidemiology among people in the Kurdistan Region, Iraq Characterization of COVID-19 in Kurdistan Region, Iraq

  Nawfal R Hussein, Ibrahim A Naqid, Zana Sidiq M. Saleem

  e2020061

  2020-08-29

  https://doi.org/10.4084/mjhid.2020.061

  1232

  PDF: 852

  HTML: 233

• The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients

  Hesham Elsabah, Mahmood B. Aldabt, Ruba Taha, Dina Sameh Soliman, Halima Elomri, Feryal Ibrahim

  e2020082

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.082

  1016

  PDF: 372

  HTML: 208

• UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)

  José Luis Piñana, Estela Giménez, Lourdes Vázquez, María Ángeles Marcos, Manuel Guerreiro, Rafael Duarte, Ariadna Pérez, Carlos de Miguel, Ildefonso Espigado, Marta González-Vicent, María Suarez-Lledó, Irene García-Cadenas, Rodrigo Martino, Angel Cedillo, Monserrat Rovira, Rafael de la Cámara, David Navarro, Carlos Solano

  e2024065

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.065

  4050

  Suppl. Files: 1159

  PDF: 1096

  Html: 185

• Treatment of relapsed/refractory CLL with Venetoclax-Rituximab during the COVID-19 pandemic: A daily-life experience in southern Italy.

  Stefano Molica, Paolo Sportoletti, Nicola Di Renzo, Pellegrino Musto, Fabrizio Pane, Francesco Di Raimondo

  e2021042

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.042

  1449

  PDF: 502

  HTML: 207

• Pidotimod in paucisymptomatic SARS-CoV2 infected patients Pidotimod in COVID-19

  Claudio Ucciferri, Barone Mirko, Jacopo Vecchiet, Katia Falasca

  e2020048

  2020-06-28

  https://doi.org/10.4084/mjhid.2020.048

  3152

  PDF: 1890

  HTML: 983

• FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator

  Claudio Ucciferri, Francesca Chiappini, Jacopo Vecchiet, Katia Falasca

  e2025057

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.057

  2746

  PDF: 993

  HTML: 610

• IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination

  Giuseppe Auteri, Simona Paglia, Camilla Mazzoni, Mattia Biondo, Marta Venturi, Andre Davide Romagnoli, Daniela Bartoletti, Michele Cavo, Nicola Vianelli, Francesca Palandri

  e2023029

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.029

  1498

  PDF: 894

  HTML: 322

• ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE

  Lijie Ma, Ling Chen

  e2026034

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.034

  195

  PDF: 273

  Suppl. Files: 49

  HTML: 42

• Intracardiac thrombosis in the three-year-old boy with normal left ventricle systolic function in MIS-C associated with COVID-19

  Stasa Krasic, Sasa Popovic, Ruzica Kravljanac, Sergej Prijic, Vladislav Vukomanovic

  e2022028

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.028

  885

  PDF: 463

  HTML: 267

• Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report

  Martina Di Palma, Elio Gentilini, Chiara Masucci, Alessandra Micozzi, Ombretta Turriziani, Antonino Mulè, Robin Foà, Maurizio Martelli, Gabriella D'Ettorre, Saveria Capria, Sabina Chiaretti

  e2022043

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.043

  1387

  PDF: 594

  HTML: 227

• Seroprevalence of anti SARS-CoV2 antibodies in Umbrian persons living with HIV SARS-CoV-2 and HIV

  chiara papalini, Francesco Paciosi, Elisabetta Schiaroli, Sara Pierucci, chiara Busti, Silvia Bozza, Antonella Mencacci, Daniela Francisci

  e2020080

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.080

  954

  PDF: 796

  HTML: 442

• SARS-CoV-2 Transmission and Outcome in Neuro-rehabilitation patients hospitalized at Neuroscience Hospital in Italy SARS CoV 2 in severe neurological patients

  Francesco Di Gennaro

  e2020063

  2020-08-29

  https://doi.org/10.4084/mjhid.2020.063

  1108

  PDF: 724

  HTML: 222

• Possible Involvement of Infection with Human rhinoviruses in Children with Kawasaki Disease

  hongbo Hu, Qing Wan, Ya-wei Li, Ying Cheng

  e2023049

  2023-08-29

  https://doi.org/10.4084/MJHID.2023.049

  692

  PDF: 568

  HTML: 194

• PREDICTORS OF MORTALITY IN MECHANICALLY VENTILATED CRITICAL PERTUSSIS IN A LOW INCOME COUNTRY: NEW RESURGENCE IN 2013.

  Aida Borgi

  e2014059

  2014-09-01

  https://doi.org/10.4084/mjhid.2014.059

  1317

  PDF: 802

  HTML: 1553

• The Mediterranean Journal of Hematology and Infectious Diseases: A New Milestone and a Hope for Researchers in Third World Countries MJHID a hope for Researchers in Third World Countries

  Nawfal R Hussein

  e2022035

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.035

  755

  PDF: 449

  HTML: 221

• GREEK CONSENSUS ON CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATMENT

  Sotirios Sachanas, Theodoros Vassilakopoulos, Maria Angelopoulou, sotirios Papageorgiou, Emmanouil Spanoudakis, Maria Bouzani, Maria Dimou, Panagiotis Panagiotidis

  e2025014

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.014

  1426

  HTML: 162

  PDF: 886

• Covid-19; Cholera and Crimean-Congo hemorrhagic fever in Iraq: A country with three outbreaks

  Nawfal R Hussein

  e2022077

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.077

  638

  PDF: 417

  HTML: 247

• EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome

  Cumali Yalçın, Bedrettin Orhan, Tuba Ersal, Mümin Şentürk, Vildan Özkocaman, Halis Akalın, Fahir Özkalemkaş

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.032

  930

  PDF: 650

  HTML: 129

• Mental well-being in patients with transfusion-dependent anemias and hemochromatosis during the SARS-CoV-2 pandemic

  Rachele Piperno, Gabriella Bertazioli, Ravasi Giulia, Raffaella Mariani, Alberto Piperno

  e2021024

  2021-02-26

  https://doi.org/10.4084/mjhid.2021.024

  1217

  PDF: 501

  HTML: 181

• Young Chronic Lymphocytic Leukemia Patient with Cat Scratch Disease Diagnosed via Next-Generation Sequencing

  Chengxin Luan, Xiuping Yang, Linlin Dong, Ying Zhu, Hongguo Zhao

  e2026007

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.007

  627

  PDF: 533

  Html: 97

• Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation Pidotimod in SARS-CoV-2 vaccination

  Claudio Ucciferri, Antonio Auricchio, Jacopo Vecchiet, Katia Falasca

  e2022023

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.023

  1134

  PDF: 572

  HTML: 232

• Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era

  Serena Vita, Emanuela Giacobini, Patrizia De Marco, Martina Rueca, Cesare Ernesto Maria Gruber, Alessia Beccacece, Laura Scorzolini, Valentina Mazzotta, Carmen Pinnetti, Priscilla Caputi, Daniele Focosi, Enrico Girardi, Andrea Antinori, Fabrizio Maggi, Alessandra D'Abramo, Emanuele Nicastri, Spallanzani COVID-19 case Investigation Team

  e2024043

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.043

  1320

  PDF: 947

  HTML: 92

• the EARLY TREATMENT WITH BAMLANIVIMAB ALONE DOES NOT PREVENT COVID-19 HOSPITALIZATION AND ITS POST-ACUTE SEQUELAE. A REAL EXPERIENCE IN UMBRIA, ITALY.

  Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Laura Martinelli Martinelli, lisa malincarne, Martina Savoia, Anna Laura Spinelli, Daniela Francisci

  e2021061

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.061

  1247

  PDF: 426

  HTML: 222

• Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia

  Zhan Su, Feng Wang

  e2025063

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.063

  900

  PDF: 504

  HTML: 181

  Suppl. Files: 334

• DIAGNOSIS AND PROGNOSIS EVALUATION OF SEVERE PNEUMONIA BY LUNG ULTRASOUND SCORE COMBINED WITH SERUM INFLAMMATORY MARKERS.

  Bo Fu, Peng Zhang, JunHua Zhang

  e2023057

  2023-10-30

  https://doi.org/10.4084/MJHID.2023.057

  1135

  PDF: 613

  HTML: 176

• PRE AND POST-MONOCLONAL INFUSION NEUTRALIZING ACTIVITY IN A SUBGROUP OF PATIENTS TREATED IN THE PRESENCE OF TWO SARS-COV-2 DOMINANT VARIANT OF CONCERN (VOCS) AND AN ONGOING VACCINATION. OVERALL CLINICAL EFFICACY OF TWO MONOCLONAL ANTIBODIES ASSOCIATION IN UMBRIA

  Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Anna Gidari, Lisa Malincarne, Sara Benedetti , Alessandra Lanzi, Sabrina Bastianelli, Sara Pierucci, Chiara busti, Daniela Francisci

  e2022050

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.050

  1682

  PDF: 553

  HTML: 236

• VIRAL ETIOLOGY OF ACUTE RESPIRATORY INFECTIONS IN PEDIATRIC PATIENTS IN LEBANON

  Khaldoun Masoud, Ghassan Matar, Ghassan Dbaibo, Geoarge F Araj, Hasan Zaraket, Rima Hanna Wakim

  e2019059

  2019-10-30

  https://doi.org/10.4084/mjhid.2019.059

  1500

  PDF: 867

  HTML: 206

• Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients

  NICOLA SGHERZA, Stefania Zucano, Angelantonio Vitucci, Antonio Palma, Francesco Tarantini, Daniela Campanale, Luigi Vimercati, Angela Maria Vittoria Larocca, Domenico Visceglie, Amalia Acquafredda, Angelo Ostuni, Daniela Di Gennaro, Carmen Vitucci, Silvio Tafuri, Pellegrino Musto

  e2022056

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.056

  1211

  HTML: 294

  PDF: 513